The American Pharmacists Association (APhA) today announced the election of Brad Tice, PharmD, MBA, FAPhA, of Thompsons Station, TN, as 2018–2019 APhA President-elect. Tice will succeed Nicki L. Hilliard, of Little Rock, AR, to the office of APhA President on March 25, 2019, at the conclusion of the 2019 APhA Annual Meeting & Exposition in Seattle, WA. 

Also elected to serve a three-year term on APhA’s Board of Trustees, beginning in March 2018, are Magaly Rodriguez de Bittner, PharmD, FAPhA, of Baltimore, MD, and Theresa Tolle, BPharm, FAPhA of Sebastian, FL. Elected as 2018–2019 Honorary President is Stanley Shaw, PhD, FAPhA, FASHP, FFIP, of Battleground, IN. All officers will be installed at the 165th APhA Annual Meeting & Exposition in Nashville, March 16–19, 2018.

Brad Tice, PharmD, MBA, FAPhA is the Director - Product Strategy and Commercialization for Cardinal Health. Dr. Tice received his Bachelor of Science degree in 1994 and PharmD in 1996 from the University of Kansas. He also earned an MBA from the Vanderbilt University Owen School of Management in 2012. His career has spanned the pharmacy spectrum working with independent, chain and hospital pharmacies through Cardinal Health, entrepreneurial start-ups, independent and chain community pharmacy practice, academia at Drake University, and managed care. His entire career has focused on elevating the profession by empowering pharmacists to improve patient care and ensuring pharmacists are recognized and compensated for their services. He served APhA as Trustee-at-Large (2014-2017) and Speaker of the APhA House of Delegates (2011-2013). He has served on the executive committee of the APhA-Academy of Pharmacy Practice and Management (APPM), as an APhA-ASP national student Member-at-Large, and in several other elected and volunteer positions. He has also served the profession in numerous other capacities including the Pharmacy Quality Alliance, serving as initial consultant and workgroup chair, on technical expert panels regarding quality measure development (NCQA, CMS), committees with AACP and AMCP, and Speaker of the House and Board of Trustees of the Iowa Pharmacy Association. His professional recognitions include: Cardinal Health’s 2015 Product Leader of the Year, APhA’s 2010 Distinguished Achievement Award in Clinical/Pharmacotherapeutic Practice, APhA—Fellow (2008), Prescott Leadership Award (2005), and the Iowa Pharmacy Association’s Young Pharmacist of the Year (2002).

Magaly Rodriguez de Bittner, PharmD, FAPhA, is a Professor, Associate Dean for Clinical Services and Practice Transformation and Executive Director of the Center for Innovative Pharmacy Solutions at the University of Maryland School of Pharmacy. Currently, she is a Fellow in Population Health at the University of Maryland Health Medical System. She received her BS in Pharmacy at the University of Puerto Rico and her PharmD at the University of Maryland. Her role as a practitioner and pharmacy faculty has led to the development of many nationally rec­ognized innovative programs, includ­ing the Giant Diabetes Education Program and the Maryland P3 Program- a pharmacist-directed MTM and chronic disease manage­ment program and prior site of the APhA Foundation Ten City Challenge- in partnership with the Maryland Pharmacists Association, government and business organi­zations. She is past director of the Community Pharmacy Residency Program and is a current preceptor. She regularly speaks at national and interna­tional forums on development and implementation of pharmacist-directed services. Her work includes collaborations with the CDC and other government agencies. She is past President of the Maryland Pharmacists Association and APhA Foundation Board, APhA Fellow and served on APhA committees and taskforces, including the Forum of the Americas. She is a recipient of the APhA Foundation Pinnacle Award for Individual Career Achievement (2015), Maryland Innovator of the Year (2014), University of Maryland Entrepreneur of the Year (2013), the American Pharmacists Association Daniel B. Smith Award (2013), the Group Pinnacle Award (2010), APhA Community Pharmacy Residency Excellence in Precepting Award (2007), and the 2005 Bowl of Hygeia. She has dedicated her career to advance pharmacy practice and the development of innovative and sustainable patient care programs to maximize the impact of pharmacists in patient care.

Theresa Tolle, BPharm, FAPhA, is owner of Bay Street Pharmacy in Sebastian, Florida for the past 19 years. Prior to owning an indepen­dent community pharmacy, she had practice experience in chain, long term care (consultant) pharmacy and hospital. Her pharmacy practice focuses on patient services such as counseling, MTM, compounding, immunizations and pharmacogenomics testing. Her professional activities have spanned local, state, and national pharmacy associations including serving as President of Florida Pharmacy Association in 2003, Treasurer of the Florida Pharmacy Political Committee since 2009, APhA-APPM Community & Ambulatory Chair 1995–1996, PAC Region 2 Board of Governors 2009–2012 and Speaker–Elect/Speaker of the House 2014–2017. Other APhA service includes Policy Committee Chair in 2010–2011, AMCP Model Audit Guidelines Task Group, 2010–2011 and CPPA Oversight Committee 2012–2013. Additional professional involvement includes mem­bership and committee work with NCPA, Cardinal Health National Advisory Board, Health First Health Plans P&T Committee and Creative Pharmacist Advisory Board. Activities outside the profession include Sebastian Chamber of Commerce Board Chair & LGA Chair, American Cancer Society Treasure Coast Council, and Sebastian River Medical Center Trustee. Tolle graduated from University of Florida in 1988. She has won several professional awards including the 2017 APhA Pharmacy Management Excellence Award, Palm Beach Atlantic University Community Pharmacy Preceptor of the Year in 2015, Bowl of Hygeia in 2012, APhA Fellow in 2011, APhA Good Government Pharmacist of the Year in 2004 and Cardinal Health’s Ken Wurster Community Leadership Award in 2011. She is blessed to be the wife of Joe and the mom of 3 wonderful children, Taryn, TJ and Taelyn.

Stanley M. Shaw, PhD, FAPhA, FASHP, FFIP is a Professor Emeritus, Nuclear Pharmacy at Purdue University College of Pharmacy. He received a B.S. in Pharmacy and M.S. in Pharmaceutical Science from South Dakota State University and a Ph.D. in Bionucleonics from Purdue. As a faculty member in Bionucleonics, he conducted radioactive tracer research in the 1960’s. In the early 1970’s, his love for pharmacy propelled him to focus on nuclear pharmacy. With this focus, he became one of the leaders in the development of nuclear pharmacy education and professional matters and in the recognition of nuclear pharmacy as a specialty practice in the profession. He was a co-organizer of the first nuclear pharmacy session held at the APhA Annual Meeting in 1974. He joined with others to petition for the formation of the Section on Nuclear Pharmacy and for recognition of nuclear pharmacy as the first specialty practice by the BPS. Following recognition he was appointed as a founding member of the BPS Specialty Council on Nuclear Pharmacy. Dr. Shaw was appointed as Vice Chairman Pro Tem of the new Section and elected as chairman twice. He served on countless nuclear pharmacy committees, presented orally at meetings, served as Section Historian as well as on the APhA House of Delegates. His involvement in APhA spans over 40 years. Dr. Shaw was recognized by APhA as a Fellow, as a recipient of the Distinguished Achievement Award in Nuclear Pharmacy and the Daniel B. Smith Practice Excellence Award. He was recognized by South Dakota State University as a distinguished alumnus in education and by the AACP as an educator. He credits his career to the Lord, the nuclear pharmacy team, and his super pharmacist wife, his rock of support.